Skip to content
Screener

Microbot Medical MBOT Q4 2025 Annual earnings

Reported March 26, 2026 · After market close

EPS-$0.04Beat by $0.02
Revenue estimate$113.3K
EPS estimate-$0.06

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$566.7K
EPS estimate-$0.09

Financials

Q4 2025

Income statement

See full
Operating income-$4.1M-20.6%
Net income-$3.5M-2.1%
EPS (diluted)-$0.04+80.0%

Balance sheet

See full
Cash & equivalents$3.9M+25.6%
Total debt$865.0K+679%
Total equity$77.6M+2,097%
Total assets$81.5M+1,252%

Cash flow

See full
Operating cash flow-$3.8M-122%
CapEx$25.0K+257%
Free cash flow-$3.8M-123%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$134.32M+608%
Enterprise value$131.27M+722%

Returns & leverage

See full
Return on equity-32.4%-15.2pp
Debt / equity0×0.0×
Current ratio23.3×+21.0×

FAQ

When did Microbot Medical report Q4 2025 earnings?
Microbot Medical (MBOT) reported Q4 2025 earnings on March 26, 2026 after market close.
What were Microbot Medical's Q4 2025 revenue and EPS?
Microbot Medical reported eps of $-0.04 for Q4 2025.
Did Microbot Medical beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.06 by $0.02.
How did Microbot Medical's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 80.0% from $-0.20.
Where can I find Microbot Medical's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001493152-26-012281) and the 10-K periodic report (0001493152-26-012935) directly on SEC EDGAR. The filing index links above go to sec.gov.